Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AACR 2022 | Reverse fate mapping of CAR-T cells in patients with large B-cell lymphoma

Zinaida Good • 12 Apr 2022
AACR 2022
B-Cell Lymphoma Lymphoma CAR-T

In this video, Zinaida Good, PhD, Stanford University, Stanford, CA, discusses reverse fate mapping of CAR-T cells in patients with large B-cell lymphoma and the importance of understanding how CAR-T cells change on the clonal level. Dr Good explains that because CAR-T therapy is extremely successful in large B-cell lymphoma, it is important to further analyze gene expression in CAR-T cells and see how this information can help researchers better understand which clones are likely to be more successful during treatment. This interview took place at the American Association for Cancer Research Annual Meeting in New Orleans, LA.

More from Zinaida Good

2:09
Using lineage tracing to define responding CAR T-cells in patients with LBCL
Zinaida Good • 9 Apr 2024
1:24
The future of CAR T-reg cells: organ transplantation & autoimmune disease
Zinaida Good • 9 Apr 2024
1:47
Lineage tracing of CAR-T cells in patients with B-cell malignancies & the value of this approach
Zinaida Good • 16 Apr 2023
1:29
Evaluating post-infusion CAR-Treg cells to identify patients resistant to CD19 CAR-T therapy
Zinaida Good • 16 Apr 2023

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals